2,3-butylene glycol has been researched along with Acute Disease in 1 studies
2,3-butylene glycol: RN given refers to cpd without isomeric designation
butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3.
Acute Disease: Disease having a short and relatively severe course.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rutstein, DD | 1 |
| Veech, RL | 1 |
| Nickerson, RJ | 1 |
| Felver, ME | 1 |
| Vernon, AA | 1 |
| Needham, LL | 1 |
| Kishore, P | 1 |
| Thacker, SB | 1 |
1 trial available for 2,3-butylene glycol and Acute Disease
| Article | Year |
|---|---|
2,3-butanediol: an unusual metabolite in the serum of severely alcoholic men during acute intoxication.
Topics: Acute Disease; Alcoholic Intoxication; Alcoholism; Animals; Butylene Glycols; Clinical Trials as Top | 1983 |